K. L. Scoggins

Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivity.

D. Selley, W. Dewey, Saheem A. Zaidi, 2013, Journal of medicinal chemistry.

Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.

P. Knapp, W. Dewey, Seth M. Dever, 2012, European journal of pharmacology.

Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists.

D. Selley, W. Dewey, Yunyun Yuan, 2011, ACS chemical neuroscience.

Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents.

D. Selley, I. Beletskaya, W. Dewey, 2012, Journal of medicinal chemistry.

6β-N-heterocyclic substituted naltrexamine derivative NAP as a potential lead to develop peripheral mu opioid receptor selective antagonists.

W. Dewey, H. Akbarali, E. Bilsky, 2012, Bioorganic & medicinal chemistry letters.

Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligands.

G. Kellogg, D. Selley, P. Mosier, 2015, Bioorganic & medicinal chemistry.

6β-N-Heterocyclic Substituted Naltrexamine Derivative BNAP: A Peripherally Selective Mixed MOR/KOR Ligand.

D. Selley, W. Dewey, Saheem A. Zaidi, 2016, ACS chemical neuroscience.

Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice

P. Knapp, W. Dewey, K. Hauser, 2016, The Journal of Pharmacology and Experimental Therapeutics.

Chronic neuropathic pain in mice reduces μ-opioid receptor-mediated G-protein activity in the thalamus

D. Selley, W. Dewey, L. Sim-Selley, 2011, Brain Research.